NewDays
Seattle, United States · Founded 2024 · $11.5M raised
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2C
- Website
- newdays.ai
- Total Funding
- $11.5M
- Last Round
- $4.5M Extension RoundOct 2025
- Rounds
- 2
About
AI-powered cognitive treatment combining clinician-led telehealth with personalized AI-guided brain exercises for people with MCI and early dementia.
Summary
NewDays is a Life Sciences company based in Seattle, United States, founded in 2024. It has raised $11.5M in total across 2 rounds, most recently a $4.5M Extension Round round in Oct 2025. Investors include General Catalyst, Madrona Venture and Highbury Group.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

